Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2012
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel diseaseVéronique Cloché, Anthony Buisson, Fanny Tréchot, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 2024
Prevalence of FGF23 elevation in patients with hypophosphatemiaCharlotte Oris, Alexandre Lautrette, Aurore Dougé, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative ProctitisGuillaume Pineton de Chambrun, Aurélien Amiot, Guillaume Bouguen, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
Journal of Crohn'S & Colitis|February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's DiseaseMarjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2012
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel diseaseVéronique Cloché, Anthony Buisson, Fanny Tréchot, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 2024
Prevalence of FGF23 elevation in patients with hypophosphatemiaCharlotte Oris, Alexandre Lautrette, Aurore Dougé, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative ProctitisGuillaume Pineton de Chambrun, Aurélien Amiot, Guillaume Bouguen, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
Journal of Crohn'S & Colitis|February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's DiseaseMarjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Pageof 17